XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenue $ 4,175 $ 2,271 $ 140,255
Research and development 476,364 377,377 1,270,295 1,203,616
Selling and marketing expenses 93,366 168,259 274,183 444,555
General and administrative 317,597 439,012 711,795 1,391,916
Total operating expenses 887,327 984,648 2,256,273 3,040,087
Operating Loss (887,327) (980,473) (2,254,002) (2,899,832)
Other income 338,067 338,067
Finance Income (expense), net: 40,245 (16,304) 98,978 (17,455)
Net Loss (509,015) (996,777) (1,816,957) (2,917,287)
Other comprehensive expenses:        
Foreign currency translation adjustment (18,044) (2,987) (24,045) (29,625)
Comprehensive loss for the period $ (527,059) $ (999,764) $ (1,841,002) $ (2,946,912)
Net Loss per Common Share        
Basic $ (0.00) $ (0.01) $ (0.01) $ (0.01)
Diluted $ (0.00) $ (0.01) $ (0.01) $ (0.01)
Average number of common shares used in computing basic and diluted loss per share 200,537,588 162,012,688 194,312,810 152,240,776